Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.
about
Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Targeting the SET and RING-ass ...... anti-cancer drug development.
@en
Targeting the SET and RING-ass ...... anti-cancer drug development.
@nl
type
label
Targeting the SET and RING-ass ...... anti-cancer drug development.
@en
Targeting the SET and RING-ass ...... anti-cancer drug development.
@nl
prefLabel
Targeting the SET and RING-ass ...... anti-cancer drug development.
@en
Targeting the SET and RING-ass ...... anti-cancer drug development.
@nl
P2860
P356
P1433
P1476
Targeting the SET and RING-ass ...... r anti-cancer drug development
@en
P2093
Pierre-Olivier Estève
Sriharsa Pradhan
P2860
P304
26243-26258
P356
10.18632/ONCOTARGET.25425
P407
P577
2018-05-25T00:00:00Z